Physician profile
Surendra B Avula
NPI 1275526071
$42,564.72
in general payments reported to CMS, 2019-2025
26 companies · $1,225 in 2025
The $1,225 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $2,639 · 2021: $3,838 · 2022: $5,475 · 2023: $4,430 · 2024: $801 · 2025: $1,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,060 · Food and Beverage: $2,602 · Travel and Lodging: $756 · Entertainment: $38.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,060.00 |
| Food and Beverage | $2,601.55 |
| Travel and Lodging | $756.03 |
| Entertainment | $38.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $25,185.84 | 2019-2022 | |
| Abbott Laboratories | $7,697.88 | 2019-2025 | Diamondback Coronary, Cardiomems |
| Philips North America LLC | $2,955.21 | 2019-2023 | |
| Medtronic Vascular, INC. | $1,970.54 | 2019 | |
| Boston Scientific Corporation | $1,063.50 | 2019-2025 | Farapulse, Watchman Flx, Watchman Access System |
| Abiomed | $576.38 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $480.49 | 2019-2024 | Xarelto |
| Biotronik INC. | $386.21 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $367.75 | 2019-2024 | Farxiga |
| Medtronic, INC. | $351.66 | 2021-2025 | Symplicity G3, Onyx Frontier |
| Novartis Pharmaceuticals Corporation | $342.75 | 2022-2025 | |
| Cardiva Medical, INC. | $214.33 | 2024-2025 | Savvywire, Optowire |
| Shockwave Medical, INC | $170.93 | 2021-2025 | |
| Edwards Lifesciences Corporation | $120.66 | 2023 | Pascal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $117.08 | 2019-2025 | Lifevest |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $98.46 | 2019 | |
| Heartflow, INC. | $87.22 | 2024-2025 | |
| Amgen INC. | $83.86 | 2021-2023 | Repatha |
| Zimmer Biomet Holdings, INC. | $74.94 | 2025 | Ribfix Titan |
| Esperion Therapeutics, INC. | $41.38 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $40.25 | 2019-2021 | |
| Opsens INC. | $38.28 | 2023 | Optowire |
| Pfizer INC. | $38.01 | 2019-2020 | |
| Johnson & Johnson Health Care Systems INC. | $25.28 | 2022 | |
| Novo Nordisk INC | $22.44 | 2024 | Wegovy |
| Cvrx, INC. | $13.39 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surendra Avula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.